Skip to results

Consultation end date

Consultation end date

Type (2 selected)


Guidance programme

Showing 1 to 10 of 10

Guidance and quality standards in consultation
TitleConsultationTypeConsultation end date
Teclistamab for treating relapsed and refractory multiple myeloma after 3 or more treatments (Review of TA869) [ID6333]Draft guidanceTechnology appraisal guidance
Elranatamab for treating relapsed and refractory multiple myeloma after 3 or more treatments [ID4026]Draft guidanceTechnology appraisal guidance
Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devicesDiagnostics consultationDiagnostics guidance
Novel home-testing devices for diagnosing obstructive sleep apnoea/hypopnoea syndromeDiagnostics consultationDiagnostics guidance
Technologies for the assessment of attention deficit hyperactivity disorder (ADHD)Diagnostics consultationDiagnostics guidance
Asthma: diagnosis, monitoring and chronic asthma managementDraft guidance consultationNICE guideline
Zilucoplan for treating antibody positive generalised myasthenia gravis [ID4008]Draft guidanceTechnology appraisal guidance
Rucaparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy [ID5100]Draft guidanceTechnology appraisal guidance
Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resection (Review of TA761) [ID5120]Draft guidanceTechnology appraisal guidance
12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (review of TA834) [ID6280]Draft guidanceTechnology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All